The Global Traumatic Brain Injuries Assessment Market was valued at USD 2.3 billion in 2025 and is estimated to grow at a CAGR of 5.2% to reach USD 4 billion by 2035.
Market expansion is driven by the increasing prevalence of head injuries, the rising number of sports-related and military-associated TBIs, and ongoing advancements in neuroimaging and diagnostic technologies. Traumatic brain injury assessment involves a comprehensive clinical, cognitive, and neurological evaluation to determine the severity, functional impact, and overall outcome of brain injuries. It incorporates neurological tests, behavioral assessments, imaging techniques, and biomarker analysis to facilitate prompt diagnosis, treatment planning, and prognosis. The market is further fueled by innovations in CT, MRI, EEG, and biomarker-based diagnostics, enabling faster and more accurate detection of mild and moderate TBIs, which were often overlooked previously. Growing adoption of AI-driven analytics, objective diagnostic tools, and blood-based screening solutions is also reshaping the industry.
The screening devices segment held an 80.1% share in 2025, due to their rapid, cost-effective, and non-invasive assessment capabilities. These devices are essential for early detection and prioritization of suspected brain injuries in emergency and point-of-care settings, driving their widespread adoption.
The hospitals segment held a 57.9% share in 2025, expected to reach USD 2.4 billion during 2026-2035. Hospitals remain the primary care centers for head injury patients, with high patient inflow demanding advanced assessment tools. Rising road traffic incidents and age-related injuries are key factors contributing to increased hospital admissions, reinforcing the need for efficient TBI evaluation solutions.
U.S. Traumatic Brain Injuries Assessment Market was valued at USD 881.6 million in 2025. North America’s demand is largely fueled by head injuries stemming from accidents, falls, and other causes, creating significant pressure on emergency care providers to adopt rapid and accurate diagnostic tools. The reliance on advanced neurodiagnostic solutions in hospitals and emergency units continues to drive the U.S. market forward.
Key players in the Global Traumatic Brain Injury Assessment Market include Philips, BrainScope, INTEGRA, RAUMEDIC, Fujifilm, Natus Medical, GE Healthcare, BIOMERIEUX, Oculogica, NIHON KOHDEN, InfraScan, SIEMENS Healthineers, COMPUMEDICS, and ZOLL Medical. To strengthen their presence, companies are pursuing strategies such as launching advanced diagnostic tools with faster turnaround times, integrating AI and machine learning into imaging platforms, and developing non-invasive biomarker-based tests. Many firms are expanding geographically to access high-growth regions and forming partnerships with hospitals, research institutions, and emergency care providers. Investment in marketing campaigns, training programs for healthcare professionals, and after-sales support ensures broader adoption and improved clinical outcomes.
This product will be delivered within 2-4 business days.
Market expansion is driven by the increasing prevalence of head injuries, the rising number of sports-related and military-associated TBIs, and ongoing advancements in neuroimaging and diagnostic technologies. Traumatic brain injury assessment involves a comprehensive clinical, cognitive, and neurological evaluation to determine the severity, functional impact, and overall outcome of brain injuries. It incorporates neurological tests, behavioral assessments, imaging techniques, and biomarker analysis to facilitate prompt diagnosis, treatment planning, and prognosis. The market is further fueled by innovations in CT, MRI, EEG, and biomarker-based diagnostics, enabling faster and more accurate detection of mild and moderate TBIs, which were often overlooked previously. Growing adoption of AI-driven analytics, objective diagnostic tools, and blood-based screening solutions is also reshaping the industry.
The screening devices segment held an 80.1% share in 2025, due to their rapid, cost-effective, and non-invasive assessment capabilities. These devices are essential for early detection and prioritization of suspected brain injuries in emergency and point-of-care settings, driving their widespread adoption.
The hospitals segment held a 57.9% share in 2025, expected to reach USD 2.4 billion during 2026-2035. Hospitals remain the primary care centers for head injury patients, with high patient inflow demanding advanced assessment tools. Rising road traffic incidents and age-related injuries are key factors contributing to increased hospital admissions, reinforcing the need for efficient TBI evaluation solutions.
U.S. Traumatic Brain Injuries Assessment Market was valued at USD 881.6 million in 2025. North America’s demand is largely fueled by head injuries stemming from accidents, falls, and other causes, creating significant pressure on emergency care providers to adopt rapid and accurate diagnostic tools. The reliance on advanced neurodiagnostic solutions in hospitals and emergency units continues to drive the U.S. market forward.
Key players in the Global Traumatic Brain Injury Assessment Market include Philips, BrainScope, INTEGRA, RAUMEDIC, Fujifilm, Natus Medical, GE Healthcare, BIOMERIEUX, Oculogica, NIHON KOHDEN, InfraScan, SIEMENS Healthineers, COMPUMEDICS, and ZOLL Medical. To strengthen their presence, companies are pursuing strategies such as launching advanced diagnostic tools with faster turnaround times, integrating AI and machine learning into imaging platforms, and developing non-invasive biomarker-based tests. Many firms are expanding geographically to access high-growth regions and forming partnerships with hospitals, research institutions, and emergency care providers. Investment in marketing campaigns, training programs for healthcare professionals, and after-sales support ensures broader adoption and improved clinical outcomes.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Product, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 8 Company Profiles
Companies Mentioned
The companies profiled in this Traumatic Brain Injuries Assessment market report include:- BIOMERIEUX
- BrainScope
- COMPUMEDICS
- FUJIFILM
- GE Healthcare
- InfraScan
- INTEGRA
- Natus Medical
- NIHON KOHDEN
- Oculogica
- PHILIPS
- RAUMEDIC
- SIEMENS Healthineers
- ZOLL Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | January 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 2.3 Billion |
| Forecasted Market Value ( USD | $ 4 Billion |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
